Abnova (Taiwan) Corp Sustainability Reports
Abnova (Taiwan) Corporation operates as a biotechnology company that manufactures and sells antibodies and proteins on an industrial scale. Its portfolio mainly includes monoclonal antibodies, polyclonal antibodies, full-length proteins, active proteins, and testing reagents.
Sector: Manufacturing
Country: Taiwan
Exchange: Taiwan Stock Exchange
FIGI: BBG001T2TKD1
5 reports from 2022 to 2025